Floatz logo

Therapeutic Asset Ratings

622 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
PF-07104091
Breast Cancer
PfizerP2CCC (50)
PIFLUFOLASTAT
Breast Cancer
M.D. Anderson Cancer CenterP2CCC (50)
Pioglitazone
Breast Cancer
Rambam Health Care CampusP2CCC (50)
POLY((N-(2-HYDROXYPROPYL)METHACRYLAMIDE)-CO-(METHACRYLOYL-GLY-PHE-LEU-GLY AMIDE WITH O-((TRANS-4-AMINOCYCLOHEXYL)CARBAMOYL)FUMAGILLOL)) (~0.91:0.09 X)
Breast Cancer
Memorial Sloan Kettering Cancer CenterP2CCC (50)
PRAVASTATIN
Breast Cancer
Institut du Cancer de Montpellier - Val d'AurelleP2CCC (50)
Pyruvate
Breast Cancer
Rigshospitalet, DenmarkP2CCC (50)
Riluzole
Breast Cancer
University of California, IrvineP2CCC (50)
Rilvegostomig
Breast Cancer
AstraZenecaP2CCC (50)
Shr-A2009
Breast Cancer
Fudan UniversityP2CCC (50)
Tart Cherry
Breast Cancer
Philip ChangP2CCC (50)
ERGOCALCIFEROLUM
Breast Cancer
Jiuda ZhaoP3CCC (49)
Ganglioside-Monosialic Acid
Breast Cancer
Sun Yat-sen UniversityP3CCC (49)
Methadon
Breast Cancer
University of UtahP3CCC (48)
Avelumab
Breast Cancer
The Christie NHS Foundation TrustP2CCC (48)
bb-1701
Breast Cancer
Eisai Inc.P2CCC (48)
Docosahexaenoic Acid
Breast Cancer
City of Hope Medical CenterP2CCC (48)
Hetrombopag
Breast Cancer
Fudan UniversityP2CCC (48)
Lisinopril
Breast Cancer
UNC Lineberger Comprehensive Cancer CenterP2CCC (48)
Methylene Blue
Breast Cancer
BTG International Inc.P2CCC (48)
Oleogel-S10
Breast Cancer
Memorial Sloan Kettering Cancer CenterP2CCC (48)
PANTOPRAZOLE
Breast Cancer
Cairo UniversityP2CCC (48)
Replens
Breast Cancer
Alta Bates Summit Medical CenterP2CCC (48)
Triamcinalone
Breast Cancer
Memorial Sloan Kettering Cancer CenterP2CCC (48)
wh002
Breast Cancer
Beijing Wehand-Bio Pharmaceutical Co., LtdP2CCC (48)
Zotatifin
Breast Cancer
Jennifer Lee Caswell-JinP2CCC (48)
Showing 251 to 275 of 622 assets
PreviousPage 11 of 25Next